Doris Losert
Impact in
-
- MicroRNA in disease regulation
-
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Ubiquitin and proteasome pathways
Papers in
-
- Cell death mechanisms and regulation 3
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 3
- Gene expression and cancer classification 1
- Melanoma and MAPK Pathways 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Volker Wacheck (8 shared papers)Daniel Cejka (4 shared papers)Sabine Strommer (3 shared papers)Wolfgang Sieghart (3 shared papers)Richard Crevenna (2 shared papers)Brett P. Monia (2 shared papers)Martin Bodingbauer (1 shared paper)Susanne Rasoul‐Rockenschaub (1 shared paper)
- Journals
- Clinical Chemistry (1 paper)Analytical Biochemistry (1 paper)Journal of Hepatology (1 paper)Cancer Biology & Therapy (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- AustriaUnited States
In The Last Decade
Doris Losert
11 papers receiving 500 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 75
- Molecular Biology 347
- Oncology 85
- Hepatology 20
- Ophthalmology 22
Countries citing papers authored by Doris Losert
This map shows the geographic impact of Doris Losert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Losert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Losert more than expected).
Fields of papers citing papers by Doris Losert
This network shows the impact of papers produced by Doris Losert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Losert. The network helps show where Doris Losert may publish in the future.
Co-authors
The 25 scholars most cited alongside Doris Losert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 207 | |
| 2 | 2005 | 81 | |
| 3 | 2005 | 53 | |
| 4 | 2003 | 51 | |
| 5 | 2001 | 40 | |
| 6 | 2007 | 23 | |
| 7 | Polymorphism of the beta-2 adrenoceptor and IOP lowering potency of topical timolol in healthy subjects. | 2005 | 22 |
| 8 | 2006 | 21 | |
| 9 | 2004 | 9 | |
| 10 | Quantitative single-cell analysis of target protein expression relative to human/murine tissue distribution in human xenografts for optimizing development of gene expression modulating therapeutics | 2005 | 1 |
| 11 | 2004 | 1 |
About Doris Losert
Doris Losert is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Ophthalmology and Animal Science and Zoology, having authored 11 papers that have together received 509 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Mechanisms and Therapy (1 paper), Gene expression and cancer classification (1 paper), Hormonal and reproductive studies (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Cancer Research (75 citations), Molecular Biology (347 citations), Oncology (85 citations), Hepatology (20 citations) and Ophthalmology (22 citations). Doris Losert has collaborated with scholars based in Austria and United States. Frequent co-authors include Volker Wacheck, Daniel Cejka, Sabine Strommer, Wolfgang Sieghart, Richard Crevenna, Brett P. Monia, Martin Bodingbauer, Susanne Rasoul‐Rockenschaub, Markus Peck‐Radosavljevic and Katharina Schmid. Their work appears in journals such as Clinical Chemistry, Analytical Biochemistry, Journal of Hepatology, Cancer Biology & Therapy and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.